Mason Kauffman of US Biologic on WKNO TV’s The Spark

The theme of The SPARK May 2020 is “Looking Out for Public Health.” Jeremy C. Park interviews Mason Kauffman of US Biologic, a Memphis-based company delivering disease prevention by providing orally delivered vaccines to address the world’s great health challenges.

Read More

US Biologic Broadens Intellectual Property Platform in Prevention of Zoonotic Disease

US Biologic, a leading oral vaccine and therapeutic delivery company, today announced that the United States Patent and Trademark Office has issued U.S. Patent #1065360 entitled “Composition & Method for Reducing Zoonotic Infectious Diseases.” The patent extends the US Biologic OrisBio™ oral-delivery technology platform in the creation of orally delivered vaccines. Press Release

Read More

Vaccinating Mice May Finally Slow Lyme Disease

Kirby Stafford, Connecticut’s state entomologist, knows only one surefire way to reduce tick populations enough to cut Lyme disease rates: killing deer. Otherwise, he says, “very little by itself really reduces tick numbers enough.” But in some Connecticut neighborhoods Stafford has been testing a new strategy, one he hopes might show real promise after years…

Read More

Long-underfunded Lyme disease research gets an injection of money—and ideas

Months after a U.S. Congress–mandated working group sounded the alarm about tickborne illnesses and urged more federal action and money, the National Institutes of Health (NIH) is readying a strategic plan for these diseases. Last week it also, serendipitously, issued a rare solicitation for prevention proposals in tickborne diseases. The new pot of money, $6…

Read More

The Growing Global Battle Against Blood-Sucking Ticks

On a balmy day in late June, Scott Williams waits for a white-footed mouse (Peromyscus leucopus) to fall asleep. Williams, a wildlife biologist with the Connecticut Agricultural Experiment Station in New Haven, has just transferred the animal from a trap to a plastic bag containing a cotton ball doused in anaesthetic. As soon as the…

Read More

“Major League” Researcher: Trela worked an internship at US Biologic this summer, holds a 4.0 GPA in biomedical engineering.

As part of his major, the shortstop needed an internship and was eager to complete one close to his second “home.” The senior, through Bumgardner, was connected with Dr. Jolieke van Oosterwijk, Chief Science Officer with an innovative biotech company called US Biologic located in downtown Memphis. The disease prevention company develops oral vaccines to…

Read More

US Biologic joins the Securing America’s Medicines and Supply Coalition

“US Biologic envisions a world where everyone has equitable access to lifesaving technologies,” stated Mason Kauffman, CEO of US Biologic. “Our mission is to reduce disease through predictive analytics and orally delivered vaccines and therapeutics delivered to the home. The SAMS Coalition will help impact policy to rebuild American infrastructure and strategic product stockpiles, and…

Read More